Kapikian AZ, James HD, Kelly SJ, et al. Isolation from man of “avian infectious bronchitis virus like” viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Diseases 1969; 119(3): 282-90.
McIntosh K, Kapikian AZ, Hardison KA, Hartley JW, Chanock RM. Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol 1969; 102(5): 1109-18.
Cavanagh D. Coronavirus IBV. Coronavirus IBV: structural characterization of the spike protein. J Gen Virol 1983; 64(12): 2577-83.
Sturman LS, Holmes KV. The molecular biology of coronaviruses Advances in virus research. Netherlands: Elsevier 1983; pp. 35-112.
Siddell SG, Walker PJ, Lefkowitz EJ, et al. Additional changes to taxonomy ratified in a special vote by the international committee on taxonomy of viruses. Arch Virol 2019; 164(3): 943-6.
King AM, Lefkowitz E, Adams MJ, Carstens EB. Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. Netherlands: Elsevier 2011; p. 1338.
Yin C. Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics 2020; 112(5): 3588-96.
Sah R, Rodriguez-Morales AJ, Jha R, et al. Complete genome sequence of a 2019 novel coronavirus (SARS-CoV-2) strain isolated in Nepal microbiol. Resour Announc 2020; 9(11): 1-3.
Satarker S, Nampoothiri M. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2. Arch Med Res 2020. Epub ahead of print
Chang D, Lin M, Wei L, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China JAMA 2020 Mar 17 323(11): 1092-3.
Amawi H, Abu Deiab GA. A Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: an overview of epidemilogy, pathogenesis, diagnostics and potential vacciences and therapeutics. Ther Deliv 2020; 11(5): 245-68.
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children 2020; 382(17): 1663-5.
Boettler T, Newsome PN, Mondelli MU, et al. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Reports 2020; p. 100113.
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; 27(2) : taaa021.
Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy. Enviro Res 2020; p. 109819.
Galbadage T, Peterson BM, Gunasekera RS. Does COVID-19 spread through droplets alone? Front Public Health 2020; 8: 163.
Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut 2020; 69(6): 973-4.
Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci 2020; 16(10): 1678.
Yi Y, Lagniton PN, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 2020; 16(10): 1753.
Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020; 76: 14-20.
Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis 2020; 20(6): 669-77.
Wu R, Wang L, Kuo HC, et al. Reviews, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): an overview of viral structure and host response. Curr Pharmacol Rep 2020; 14(4): 408-12.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study 2020; 395(10223): 507-13.
Organization WH. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). Geneva 2020.
Kakodkar P, Kaka N, Baig MJC. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus 2020; 12(4) e7560
Wei WE. Presymptomatic transmission of SARS-CoV-2-Singapore January 23-March 16, 2020. MMWR morbidity and mortality weekly Report 2020; 69(14): 411-5.
McMichael TM, Clark S, Pogosjans S. COVID-19 in a long-term care facility-King County, Washington February 27-March 9, 2020. MMWR Morbidity and Mortality Weekly Report 2020; 69(12): 339-42.
Loeffelholz MJ, Tang YW. infections, Laboratory diagnosis of emerging human coronavirus infectionsthe state of the art 2020; 9(1): 747-56.
McIntosh K. Coronaviruses: A Comparative Review.Current Topics in Microbiology and Immunology/Ergebnisse der Mikrobiologie und Immunitätsforschung Heidelberg. Springer 2020.
Radiology ACR. ACR recommendations for the use of chest radiography and computed tomography (CT) for suspected COVID-19 infection 2020.
Amawi H, Abu Deiab G, Aljabali A. COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv 2020; 11(4): 245-68.
Vashist SK. In Vitro Diagnostic assays for COVID-19: recent advances and emerging trends. Diagnostics 2020; 10(4): 202.
Fani M, Teimoori A, Ghafari SJ F V. Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections. Future Virol 2020. Epub ahead of print
McCreary EK. Coronavirus disease 2019 treatment: a review of early and emerging options, Open Forum Infectious Diseases. Oxford University Press US 2020; 7(4) : ofaa105.
Tu Y-F, Chien C-S, Yarmishyn AA, et al. A review of SARS-CoV-2 and the ongoing clinical trials. Int J Mol Sci 2020; 21(7): 2657.
Kadri H, Lambourne O A, Mehellou Y J C. Niclosamide, a drug with many (re) purposes 2018; 13(11): 1088-91.
Wu R, Wang L, Kuo H-CD, et al. An update on current therapeutic drugs treating COVID-19 2020; 1. [Epub ahead of print]
Zhang L, Lin D, Kusov Y, et al. 2020.
Cosgrove S. Kucers the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. 7th ed. United States: CRC Press 2017; pp. 2531-2.
Yao TT, Qian JD, Zhu WY, Wang Y, Wang G. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease‐19 treatment option. J Med Virol 2020; 92(6): 556-63.
Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses 2006.
Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine 2006.
Rolain JM, Colson P, Raoult D. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007; 30(4): 297-308.
Jie Z, He H, Xi H, Zhi Z. Multicenter collaboration group of department of science and technology of Guangdong Province and health commission of Guangdong province for chloroquine in the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 2020; 10: 1001-0939.
FDA cautions against use of hydroxychloroquine or chloroquine for COVID-19 outside of the hospital setting or a clinical trial due to risk of heart rhythm problems 2020.
Kalil A. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics 2020.